Biotechnology Stocks I: Returns for Xenon Pharmaceuticals Inc. (XENE)
XENE has no dividends.
Table and Chart of XENE Performance
See what a $1,000 investment in XENE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| XENE Returns | |
|---|---|
| Start Date | Jan-30-2015 |
| Start Price | $17.79 |
| End Date | Jan-15-2025 |
| End Price | $40.13 |
| # Prices | 121 |
| Min Date | Nov-30-2017 |
| Min Price | $2.45 |
| Max Date | Feb-29-2024 |
| Max Price | $47.20 |
| Total Return | 125.58% |
| Annualized Return | 8.40% |
| Current Value of $1,000 Purchase | $2,256 |
| Number Returns | 7,260 |
| Average Return | 202.28% |
| Number Profitable Returns | 5,981 |
| Percent Profitable Returns | 82.38% |
| Number Unprofitable Returns | 1,279 |
| Percent Unprofitable Returns | 17.62% |
| Profitable to Unprofitable Returns Ratio | 4.68 |
| XENE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,022,900,000 |
| Beta | 1.251 | Price to Sales | 181.44 |
| Earnings per Share | $-2.8100 |
| PE Ratio | None |
| PE to Growth Ratio | -0.06 |
| Price to Book | 3.789 |
| PRICE DATA | |
| 52 Week High | $50.99 |
| 52 Week Low | $35.53 |
| Analyst Target Price | $57.67 |
| 50-Day Moving Average | $41.02 |
| 200-Day Moving Average | $40.55 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -26.7% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
XENE Compare Returns with S&P 500
XENE Trendline Chart
XENE Moving Average Chart
XENE Stock Return Map - See Patterns of Gains and Losses
XENE Stock Returns/Purchase Dates